Replies to post #332775 on Amarin Corp Plc (AMRN)

[iryokabu]

Amarin may refer to Novartis's Entresto to increase V's script.

1) Entresto Central for insurance coverage
https://www.hcplive.com/view/real-world-challenges-to-prescribing-sacubitrilvalsartan-for-patients-with-heart-failure-

2) Value based contract
https://www.managedhealthcareexecutive.com/view/novartis-signs-value-based-pricing-entresto

I am not sure if these were/have been effective or not.

[rafunrafun]

Sripts for week ending April 2, 2021 (including Good Friday).

Overall drug TRx are +0.4% w/w.

Vascepa
TRx 82,317; -1.0% w/w; -0.2% y/y
NRx 37,662; -3.0% w/w; +2.2% y/y
Ref 44,655; +0.8% w/w; -2.1% y/y

Generic Vascepa
TRx 8,093; -16.2% w/w; As % of total V: 9.0%
NRx 4,501; -19.5% w/w; As % of total V: 10.7%
Ref 3,592; -11.8% w/w; As % of total V: 7.4%

Lovaza (Generic & Brand)
TRx 61,170; -1.5% w/w; -0.1% y/y
NRx 30,630; -2.3% w/w; +6.1% y/y
Ref 30,540; -0.6% w/w; -5.6% y/y